Lithium Americas Plunges as JPMorgan Slams the Brakes with 'Sell' Rating After Recent Highs
Hillenbrand's Fading Fortune: Why It's Time to Bid Farewell
Altria Group: The Smoke Clears, Revealing a 'Sell' Signal
Wall Street Reacts: Top Stock Moves and Analyst Insights Shaping Thursday's Market
McCormick's Q3: A Deep Dive into Volume-Driven Growth and a Prudent Hold
Tech Titan Under Pressure: Jefferies Slaps 'Sell' Rating on Apple, Predicting a Steep 20% Decline
Political Earthquake Rocks Lithium Americas: Canaccord Downgrades to Sell Post-Trump Stake Disclosure
Nuclear Aspirations Hit Reality Check: Oklo and NuScale Plunge on BofA Downgrade
The GLP-1 Gold Rush: Why Morgan Stanley Just Downgraded Novo Nordisk Amid Fierce Competition
Volaris Navigates Turbulent Skies: A Prudent Downgrade Amidst Macroeconomic Headwinds
Morgan Stanley Delivers a Reality Check: Wells Fargo's Path Ahead Looks Bumpy
Apellis Pharmaceuticals Faces Investor Jitters as Goldman Sachs Issues "Sell" Rating on Escalating Competitive Threats
The Tides Are Turning: Why Turtle Beach Faces a Stormy Outlook and a Deserved Downgrade
Apple's Innovation Slump: DA Davidson Delivers a Downgrade After 'Uninspired' Product Reveals
Navigating the Cosmic Currents: Planet Labs Soars, EchoStar Eyes Starlink, and AST SpaceMobile Faces Turbulence
LifeVantage Faces a Reckoning: Disappointing Q4 Results and Bleak Outlook Trigger Downgrade
Occidental Petroleum's Bull Run Hits a Wall: Piper Sandler Downgrades OXY